{"id":56205,"date":"2023-04-25T18:03:21","date_gmt":"2023-04-25T16:03:21","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/"},"modified":"2023-04-25T18:03:21","modified_gmt":"2023-04-25T16:03:21","slug":"reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/","title":{"rendered":"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer"},"content":{"rendered":"
\n

\nLevinthal joins Reperio as company positions for significant commercial growth.<\/i><\/p>\n

PORTLAND, Ore.–(BUSINESS WIRE)–Reperio Health<\/a>, the only provider of at-home, comprehensive health screenings with instant results, today announced the appointment of Naomi Levinthal as Chief Growth Officer. In her new role, Levinthal will lead Reperio\u2019s commercial operations and strategy as the company continues to gain traction among its various healthcare industry clients.<\/p>\n

<\/a><\/p>\n

\nWith nearly 20 years of experience as a successful business leader, seasoned healthcare IT and digital health advisor, Levinthal joins Reperio from Memora Health where she served as Vice President of Strategy and Partnerships. During her tenure, Levinthal drove significant growth across hospitals and health systems, digital health, and life sciences market segments, and developed valuable commercial partnerships. Previously, she also served as Vice President of Product Strategy and Partnerships with AVIA Health, and Managing Director at the Advisory Board Company (now Optum).<\/p>\n

\n\u201cThe Reperio at-home screening kit allows anyone to know their health risks 24\/7, and is able to address a number of urgent healthcare needs across our industry,\u201d says Levinthal. \u201cReperio can transform wellness programs for employers, provide population health insights for care teams, and expand access to care in retail pharmacies. I am so honored to join a company that can positively impact the entire healthcare ecosystem and bring my expertise in building high-performing teams and growing startups.\u201d<\/p>\n

\nEarlier this year, Reperio announced<\/a> its first patent for the technology that powers the company\u2019s biometric home-based screening service. Reperio\u2019s flagship at-home screening kit utilizes multiple FDA-cleared medical devices in one coordinated end-user experience to measure key health metrics from the comfort of home or at in-person screening events.<\/p>\n

\n\u201cWe\u2019re thrilled to welcome Naomi and bring her impressive set of skills and relationships to our sales, marketing, and customer teams,\u201d says Travis Rush, CEO and Co-Founder of Reperio. \u201cStaffing shortages, health inequities, and clinician burnout have placed a huge strain on our healthcare system\u2014with many patients and consumers in the dark about their health status. With Naomi on board, we are confident that our solution will reach into every corner of our healthcare industry to influence the future of preventive health and wellness.\u201d<\/p>\n

\nTo learn more about Reperio visit www.reperiohealth.com<\/a>.<\/p>\n

\nAbout Reperio Health<\/b><\/p>\n

\nReperio takes health screenings out of the lab and delivers instant results at home. Reperio supplies employers and healthcare providers with patented screening kits that pair with a mobile app to assess key health indicators, like cholesterol, glucose levels and blood pressure, in less than 30 minutes. This solution helps individuals quickly identify steps to better health and improves on costly, complicated screening methods employed today. For more information, visit www.reperiohealth.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nInnsena for Reperio
\n
Erin Van Zomeren
\n
reperio@innsena.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Levinthal joins Reperio as company positions for significant commercial growth. PORTLAND, Ore.–(BUSINESS WIRE)–Reperio Health, the only provider of at-home, comprehensive health screenings with instant results, today announced the appointment of Naomi Levinthal as Chief Growth Officer. In her new role, Levinthal will lead Reperio\u2019s commercial operations and strategy as the company continues to gain traction … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56205","6":"format-standard","7":"category-industry"},"yoast_head":"\nReperio Health Welcomes Naomi Levinthal as Chief Growth Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Levinthal joins Reperio as company positions for significant commercial growth. PORTLAND, Ore.–(BUSINESS WIRE)–Reperio Health, the only provider of at-home, comprehensive health screenings with instant results, today announced the appointment of Naomi Levinthal as Chief Growth Officer. In her new role, Levinthal will lead Reperio\u2019s commercial operations and strategy as the company continues to gain traction ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-25T16:03:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230425005207\/en\/1772526\/21\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer\",\"datePublished\":\"2023-04-25T16:03:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/\"},\"wordCount\":464,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005207\\\/en\\\/1772526\\\/21\\\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/\",\"name\":\"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005207\\\/en\\\/1772526\\\/21\\\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg\",\"datePublished\":\"2023-04-25T16:03:21+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005207\\\/en\\\/1772526\\\/21\\\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230425005207\\\/en\\\/1772526\\\/21\\\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/","og_locale":"en_US","og_type":"article","og_title":"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer - Pharma Trend","og_description":"Levinthal joins Reperio as company positions for significant commercial growth. PORTLAND, Ore.–(BUSINESS WIRE)–Reperio Health, the only provider of at-home, comprehensive health screenings with instant results, today announced the appointment of Naomi Levinthal as Chief Growth Officer. In her new role, Levinthal will lead Reperio\u2019s commercial operations and strategy as the company continues to gain traction ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-25T16:03:21+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230425005207\/en\/1772526\/21\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer","datePublished":"2023-04-25T16:03:21+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/"},"wordCount":464,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230425005207\/en\/1772526\/21\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/","url":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/","name":"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230425005207\/en\/1772526\/21\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg","datePublished":"2023-04-25T16:03:21+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230425005207\/en\/1772526\/21\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230425005207\/en\/1772526\/21\/636eaee32c89f771ae8a8e42_logo_reperio_registered.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/reperio-health-welcomes-naomi-levinthal-as-chief-growth-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Reperio Health Welcomes Naomi Levinthal as Chief Growth Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56205","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56205"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56205\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56205"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56205"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56205"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}